CD300ld blockade overcomes PMN-MDSC-mediated vaccine resistance in advanced tumors
Background While cancer vaccines have demonstrated promising clinical potential, their therapeutic efficacy against advanced tumors remains suboptimal, highlighting the critical need to elucidate resistance mechanisms and develop targeted solutions. We previously developed a stimulator of interferon...
Furkejuvvon:
| Váldodahkkit: | , , , , , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
BMJ Publishing Group
2026-01-01
|
| Ráidu: | Journal for ImmunoTherapy of Cancer |
| Liŋkkat: | https://jitc.bmj.com/content/14/1/e013336.full |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|